Pseudocannabinoid H4CBD improves glucose response during advanced metabolic syndrome in OLETF rats independent of increase in insulin signaling proteins
Abstract Cannabidiol (CBD) use has grown exponentially more popular in the last two decades, particularly among older adults (>55 yr),…